21 May 2013
Keywords: genentech, refuses, comment, roche, merger, usa-based, refused
Article | 20 October 2008
USA-based Genentech refused to comment on its possible merger with Swiss drug major Roche in its third-quarter conference call, leaving
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 October 2008
20 May 2013
© 2013 thepharmaletter.com